GlassScriptPhysician profile
Jeffrey S Ispirescu
NPI 1952345241
$2,542.62
in general payments reported to CMS, 2019-2025
20 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2020: $226 · 2021: $440 · 2022: $265 · 2023: $419 · 2024: $537 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,423.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $885.04 | 2019-2024 | Senza |
| Globus Medical, INC. | $354.22 | 2025 | Vyrsa V1, Senza |
| Boston Scientific Corporation | $246.55 | 2019-2025 | G4 Rf Generator, Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $176.15 | 2019-2021 | |
| Si-Bone, INC. | $137.12 | 2023-2025 | |
| Medtronic, INC. | $120.32 | 2021-2024 | Synchromedii, Intellis Adaptivestim |
| Abbvie INC. | $109.31 | 2021-2025 | |
| Allergan, INC. | $94.23 | 2020-2022 | |
| Nalu Medical, INC. | $69.03 | 2023 | Nalu Neurostimulation System |
| Pfizer INC. | $61.41 | 2019-2024 | |
| Saluda Medical Americas, INC. | $59.06 | 2024-2025 | Evoke |
| Biohaven Pharmaceutical Holding Company LTD. | $34.05 | 2022 | |
| Biodelivery Sciences International, INC. | $33.99 | 2021 | |
| Lilly USA, LLC | $30.57 | 2023 | Emgality |
| Medtronic USA, INC. | $28.53 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $26.40 | 2020 | |
| Relievant Medsystems, INC. | $24.09 | 2023 | Intracept |
| Averitas Pharma INC. | $19.46 | 2024 | Qutenza |
| Biohaven Pharmaceuticals, INC. | $16.98 | 2021 | |
| Bioventus LLC | $16.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Ispirescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.